Enzon Pharmaceuticals, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was USD 8,000 compared to USD 2,000 a year ago. Operating loss was USD 407,000 compared to USD 325,000 a year ago. Net loss was USD 407,000 compared to USD 325,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the nine months, total revenue was USD 18,000 compared to USD 158,000 a year ago. Operating loss was USD 883,000 compared to USD 715,000 a year ago. Net loss was USD 885,000 compared to USD 717,000 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.